ESR1 and breast carcinoma: MALAT1 is significantly upregulated in breast cancer, especially in ER+ and HER2+ tumors, and MALAT1 is required for breast cell proliferation, migration and invasion, as knockdown of MALAT1 results in slower tumor growth and a reduction in metastasis, indicating its role in cancer development and progression [65–69].